Finally Some Progress For Esophageal Cancer Patients — Two Immunotherapy Drugs Are Boosting Survival

Updated February 3rd, 2022

Finally Some Progress For Esophageal Cancer Patients — Two Immunotherapy Drugs Are Boosting Survival

How immunotherapies are changing the treatment landscape for people with esophageal cancer, and how to know if you're a good candidate for one of these drugs.

NOW
PLAYING
Understanding PI3K Inhibitors: How Can This Type of Targeted Therapy Treat CLL?
NOW
PLAYING
Understanding BCL-2 Inhibitors: How Can This Targeted Therapy Treat CLL?
NOW
PLAYING
How Does Atezolizumab (Tecentriq) Treat Lung Cancer?
NOW
PLAYING
How is Melanoma Treated After Surgery?
NOW
PLAYING
April Is Testicular Cancer Awareness Month – Here's What You Should Know
NOW
PLAYING
Obinutuzumab for CLL

SurvivorNetTV.
Hope. Science.
Inspiration.

WATCH NOW
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.